• Nonivamide: Capsaicin Analog for Cancer & Neuroimmune Assays

  2026-05-19

  Leverage Nonivamide, a selective TRPV1 agonist, to unlock robust anti-proliferative and neuroimmune workflows. This guide details stepwise protocols, cross-model troubleshooting, and practical insights directly informed by the latest reference breakthroughs.

• FLT3–TAZ Axis Drives Drug Resistance in BP-CML: New Insights

  2026-05-18

  Shin et al. (2023) redefined the role of FLT3 signaling in blast phase chronic myeloid leukemia (BP-CML), uncovering a distinct FLT3+ subgroup with poor prognosis and resistance to BCR::ABL1 TKIs. Their multi-omics approach demonstrated that targeting FLT3, particularly in combination with existing therapies, can overcome resistance mechanisms and improve therapeutic outcomes.

• Fosinopril Sodium: Integrative Pharmacology for Cardiovascul

  2026-05-18

  Explore the advanced pharmacology of Fosinopril sodium as a potent ACE inhibitor. This article provides a unique, mechanism-driven analysis for cardiovascular disease research, emphasizing renal hemodynamics and translational assay design.

• Organic Cation Transporter Response to Olsalazine in Aedes a

  2026-05-17

  Kennel and Rouhier (2025) investigated how Aedes aegypti mosquitoes physiologically process xenobiotic dyes, including the mesalamine dimer Olsalazine Sodium, focusing on excretion profiles and transporter gene expression. Their findings highlight the structural dependence of xenobiotic clearance and mortality, providing a foundation for targeting transporter mechanisms in mosquito vector control strategies.

• Phosbind Acrylamide: Transforming Phosphorylation SDS-PAGE D

  2026-05-16

  Phos binding reagent (Phosbind) acrylamide enables fast, antibody-free protein phosphorylation analysis directly during SDS-PAGE, overcoming bottlenecks of traditional phospho-protein detection. Its workflow-centric design allows for precise, reproducible mobility shift assays in signaling research—especially for complex stress response pathways.

• BIBP 3226 trifluoroacetate: Precision Dissection of the Adip

  2026-05-15

  Unlocking the role of BIBP 3226 trifluoroacetate in adipose-neural axis research, this article explores its advanced application for dissecting NPY/NPFF signaling in cardiovascular and neurobiological contexts. Discover nuanced assay design guidance and translational insights beyond conventional protocols.

• EPZ-6438: Advanced EZH2 Inhibitor Workflows in Cancer Resear

  2026-05-15

  EPZ-6438 enables precise, reproducible modulation of the polycomb repressive complex 2 (PRC2) pathway for epigenetic cancer research. This article details stepwise experimental design, troubleshooting strategies, and highlights novel applications in HPV-associated cervical cancer models.

• Mianserin HCl: Optimizing 5-HT2 Antagonist Workflows in Rese

  2026-05-14

  Mianserin HCl enables precise modulation of serotonin receptor pathways, with proven advantages in both psychiatric disorder models and emerging antipathogenic assays. This article details evidence-backed protocols, troubleshooting strategies, and advanced workflow enhancements that unlock the full research value of this distinctive 5-HT2 receptor antagonist.

• Difloxacin HCl: Redefining Antimicrobial and MDR Research Fr

  2026-05-14

  This in-depth thought-leadership article explores Difloxacin HCl’s dual mechanistic impact—as a quinolone antimicrobial antibiotic and an MDR reversal agent—at the intersection of infectious disease and oncology research. We bridge mechanistic insight into DNA gyrase inhibition with translational workflow guidance and competitive intelligence, referencing recent cell cycle checkpoint research and best practices for experimentalists.

• Biotin-16-UTP: Practical Guide for RNA Labeling and Purifica

  2026-05-13

  Biotin-16-UTP enables precise biotin-labeling of RNA during in vitro transcription, simplifying workflows for RNA detection, purification, and interaction studies. It is best suited for molecular biology protocols requiring high-purity, biotin-labeled RNA, but should not be used in diagnostic or medical applications due to research-only designation.

• Ruxolitinib Phosphate: Precision JAK/STAT Modulation for Tra

  2026-05-13

  This article illuminates the mechanistic, experimental, and translational significance of Ruxolitinib phosphate (INCB018424) for researchers modeling JAK/STAT-driven disease. Integrating recent breakthroughs in mitochondrial dynamics and cell death with strategic workflow guidance, we bridge the gap between target validation and advanced disease modeling, offering actionable insight for laboratory and preclinical innovation.

• Lipidated Nanophotosensitizers Disrupt TEVs to Inhibit Metas

  2026-05-12

  A recent study in Nature Cancer introduces a lipidated nanophotosensitizer strategy that concurrently inhibits tumor growth and metastasis by targeting tumor extracellular vesicle (TEV) pathways. By enabling both real-time tracing and photodynamic disabling of TEVs, this approach provides a new paradigm for antimetastatic therapy and highlights the importance of selective membrane trafficking inhibition for cancer research.

• Sodium Picosulfate: Translational Leverage in Gut–Brain Axis

  2026-05-12

  This thought-leadership article explores the mechanistic, experimental, and translational frontiers of sodium picosulfate in gut–liver–brain axis research. Integrating recent neuroinflammation imaging breakthroughs, it provides strategic guidance for researchers seeking to bridge chronic constipation management with emerging models of hepatic encephalopathy and neuroimmune modulation. APExBIO’s high-purity sodium picosulfate is positioned as an enabling reagent for reproducible, protocol-driven advances in this rapidly evolving field.

• Flubendazole: Elevating Autophagy Modulation in Cancer Biolo

  2026-05-11

  Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) sets a new standard for autophagy modulation research with its robust DMSO solubility and high purity. This article unpacks real-world experimental workflows, troubleshooting strategies, and cross-disease applications, translating recent mechanistic evidence into actionable guidance for advanced autophagy and cancer biology research.

• Repurposing Natural Compounds for Inhibiting SARS-CoV-2 Prot

  2026-05-11

  This study applies molecular docking and dynamics to screen natural compounds—including vitamins—as inhibitors of the SARS-CoV-2 main protease (3CLpro) and spike protein RBD. The findings highlight safe, accessible candidates for disrupting virus entry and replication, framing new avenues for antiviral therapeutics research.

15913 records 1/1061 page Next 12345 下5页 Last page